➼ Pages to Conquer

➼ More Pages

Wednesday, October 29, 2014

JDRF-Funded Islet Encapsulation Program Reaches Historic Milestone

VERY EXCITING DIABETES NEWS TODAY!!


 First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy

New York, NY, October 29, 2014 — JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today that JDRF-funded partner, ViaCyte, Inc., a leading regenerative medicine company, has for the first time ever implanted a person with type 1 diabetes (T1D) with an experimental encapsulated cell therapy product candidate, called VC-01TM, which is being developed for the treatment of T1D. This individual, and others to follow, is participating in a trial to evaluate the safety and efficacy of the VC-01 product candidate, a potential replacement source of insulin-producing cells.

Read the whole story here:

http://jdrf.org/press-releases/jdrf-funded-islet-encapsulation-program-reaches-historic-milestone/?utm_source=ViacyteImplantOct2014&utm_medium=email&utm_campaign=InsiderNews&s_src=email&s_subsrc=InsiderNews_ViacyteImplantOct2014


No comments:

Post a Comment

➼ Please leave a comment, help keep me motivated to blog. Your email address will not be published and you will not receive any spam. Any comments with links or spam will not be published so do not waste your time.